Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer Therapy.

Mehta, Ranjit K; Shukla, Sushmita; Ramanand, Susmita G; Somnay, Vishal; Bridges, Alexander J; Lawrence, Theodore S; Nyati, Mukesh K

Mehta, Ranjit K; Shukla, Sushmita; Ramanand, Susmita G; Somnay, Vishal; Bridges, Alexander J; Lawrence, Theodore S; Nyati, Mukesh K.

Afiliación

Mehta RK; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Shukla S; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
Somnay V; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Bridges AJ; School of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
Lawrence TS; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Nyati MK; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address: nyati@umich.edu.

Transl Oncol ; 14(8): 101140, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34107419

Palabras clave

Cell-Penetrating Peptide; EGFR; HNSCC; Lung Cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google